Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
CVI Investments, Inc. | 90,988 4.900% |
-18,310 (-16.75%) |
Filing History |
| 2025-01-23 3:45 pm Purchase |
2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO |
Orca Capital AG | 514,965 9.900% |
514,965 (New Position) |
Filing History |
| 2025-01-17 4:44 pm Purchase |
2025-01-13 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 530,171 9.990% |
439,184 (+482.69%) |
Filing History |
| 2024-12-27 5:05 pm Purchase |
2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 90,987 4.990% |
45,782 (+101.28%) |
Filing History |
| 2024-12-26 2:19 pm Purchase |
2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO |
CVI Investments, Inc. | 109,298 7.300% |
109,298 (New Position) |
Filing History |
| 2024-11-13 11:20 am Purchase |
2024-09-30 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 45,205 4.990% |
45,205 (New Position) |
Filing History |
| 2024-02-06 10:30 am Purchase |
2023-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 99,045 9.990% |
99,045 (New Position) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 90,204 5.600% |
82,687 (+1100.00%) |
Filing History |
| 2022-02-11 07:46 am Purchase |
2021-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 7,517 5.700% |
3,393 (+82.28%) |
Filing History |
| 2022-01-20 09:51 am Sale |
2021-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Empery Asset Management, LP | 7,306 4.990% |
-1,024 (-12.30%) |
Filing History |
| 2021-02-19 11:21 am Purchase |
2021-02-12 | 13G | Phio Pharmaceuticals Corp. PHIO |
Empery Asset Management, LP | 8,330 6.760% |
8,330 (New Position) |
Filing History |
| 2021-02-16 10:03 am Sale |
2020-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
CVI Investments, Inc. | 2,119 4.000% |
-1,846 (-46.55%) |
Filing History |
| 2021-01-29 06:18 am Purchase |
2020-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 4,124 7.200% |
2,380 (+136.51%) |
Filing History |
| 2021-01-05 07:45 am Purchase |
2020-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
SABBY MANAGEMENT LLC | 2,671 11.000% |
951 (+55.33%) |
Filing History |